Grünenthal is a global leader in pain management and related diseases. As a science-based, fully-integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on working towards our vision of a world free of pain.
Grünenthal is headquartered in Aachen, Germany, and has affiliates in 28 countries across Europe, Latin America and the US. Our products are available in approx. 100 countries. In 2022, Grünenthal employed around 4,400 people and achieved revenues of € 1.7 bn.
More Information on www.grunenthal.com and in our Annual Report: https://www.grunenthal.com/-/media/projects/corporatewebsite/_shared/pdf/publications/en/grunenthal-reports-2023.pdf?rev=24163e2530ea426bba6999c9660bb3ac
